- Health, disability, and elder law
- International trade and investment law
- Tax law and policy
PhD (Cambridge) 2004
LLB (Toronto) 1997
MA (Toronto) 1993
BA (Alberta) 1992
Barbara von Tigerstrom has been a member of faculty at the College of Law since 2005 and a full professor since 2013. She served as the College’s Associate Dean, Research and Graduate Studies, from 2012-15. Previously she worked at the Supreme Court of Canada, the University of Alberta Health Law Institute, and the University of Canterbury School of Law. She holds a PhD in law from the University of Cambridge.
Professor von Tigerstrom’s main areas of teaching and research are health law, public health law and policy, food and drug regulation, and tort law. She has held research grants from the Canadian Institutes of Health Research (CIHR), the Stem Cell Network, and Genome Canada. She has received several awards for excellence in teaching and research, including the Canadian Association of Law Teachers Prize for Academic Excellence and the USSU Teaching Excellence Award.
Professor von Tigerstrom is a member of the CIHR Stem Cell Oversight Committee, the Law Reform Commission of Saskatchewan, and the Canadian Blood Services Bioethics Advisory Committee.
Courses Currently Taught
B. von Tigerstrom & E. Harris, 2016. Access to Experimental Treatments: Comparative Analysis of Three Special Access Regimes. Journal of Law and Medicine, 24: 119-49.
Y. Le Bodo, M.-C. Paquette & P. De Wals, Taxing soda for public health: A Canadian perspective, Springer, 2016 (expert reviewers B. von Tigerstrom and E. Guindon), http://iucpq.qc.ca/fr/taxing-soda-for-public-health
B. von Tigerstrom, 2016. The Patient’s Voice: Patient Involvement in Medical Product Regulation. Medical Law International, 16(1-2): 27-57,http://mli.sagepub.com/content/16/1-2/27.full.pdf?ijkey=9hSglbAFrTjGgwE&keytype=finite.
S. Gibson & B. von Tigerstrom, 2015. Orphan Drug Incentives in the Pharmacogenomics Context: Policy Responses in the U.S. and Canada. Journal of Law and the Biosciences, 2(2): 263-91.
B. von Tigerstrom, 2015. Consenting to Physician-Assisted Death: Issues Arising from Carter v. Canada (Attorney General). Saskatchewan Law Review, 78(2): 221-27.
B. von Tigerstrom, 2015. Revising the regulation of stem cell-based therapies: critical assessment of potential models. Food and Drug Law Journal, 70(2):315-37.
B. von Tigerstrom, 2015. Human tissue legislation and a new medical paradigm: governing tissue engineering in Canada. McGill Journal of Law and Health, 8(2): S1-S56 http://mjlh.mcgill.ca/articles.php?article_id=72
B. von Tigerstrom, 2014. Canada. In T. Voon, A. Mitchell and J. Liberman (eds.), Regulating Tobacco, Alcohol and Unhealthy Foods: The Legal Issues, 212-31. New York: Routledge.
E. Ulmer and B. von Tigerstrom, 2014. Legal and Policy Frameworks for Clinical-grade Stem Cell Banking. Health Law Review 21(3): 5-13.
K.L. Fisher, A. Mawani, B. von Tigerstrom, T. Larre, C. Cameron, K.E. Chad, B. Reeder and M.S. Tremblay, 2013. Awareness and Use of Canada’s Children’s Fitness Tax Credit. Canadian Tax Journal, 61(3): 599-632.
B. von Tigerstrom, 2013. How Do International Trade Obligations Affect Policy Options for Obesity Prevention? Lessons from Recent Developments in Trade and Tobacco Control. Canadian Journal of Diabetes, 37(3): 182-188.
Taxing Sugar-Sweetened Beverages for Public Health: Legal and Policy Issues in Canada. Alberta Law Review, (2012) 50(1): 37-64.
Regulation of Stem Cell-Based Therapies in Canada: Current Issues and Concerns. Stem Cell Reviews and Reports, (2012) 8: 623-38 (with T.M. Nguyen and B.M. Knoppers).
Tobacco Control and the Law in Canada. In T.M. Bailey, T. Caulfield and N.M. Ries (eds.), Public Health Law and Policy in Canada (3rd ed.). Toronto: LexisNexis Canada, 2012.
Law and the Promotion of Healthy Nutrition and Physical Activity. In T.M. Bailey, T. Caulfield and N.M. Ries (eds.), Public Health Law and Policy in Canada (3rd ed.). Toronto: LexisNexis Canada, 2012 (with N. Ries).
How to Build (and Regulate) a Body Part: Regulating Tissue Engineered Products in Canada. Health Law Journal, (2011) 19: 83-123.
The Food and Drug Administration, Regenerative Sciences, and the Regulation of Autologous Stem Cell Therapies. Food and Drug Law Journal, (2011) 66: 479-506.
Public Health. In C. Flood, J. Downie and T. Caulfield (eds.), Canadian Health Law and Policy (4th ed.), 539-73. Toronto: LexisNexis Canada, 2011.
Using the Tax System to Promote Physical Activity: Critical Analysis of Initiatives in Canada. American Journal of Public Health, (2011) 101(8): e10-e16 (with T. Larre and J. Sauder).
Federal Health Legislation after the Assisted Human Reproduction Act Reference. Saskatchewan Law Review, (2011) 74(1): 33-43.
Law and Policy Interventions to Prevent Chronic Disease: The Challenges of Evidence-Based Public Health. In R. Kouri and C. Régis (eds.), Les grands défis en droit et politiques de la santé / Grand Challenges in Health Law and Policy, 323-51. Cowansville, Quebec: Editions Yvon Blais, 2010.
Legal Interventions to Address Obesity: Assessing the State of the Law in Canada. U.B.C. Law Review, (2010) 43(2): 361-416.
Mandatory nutrition disclosure for restaurants: Is menu labelling coming to Canada? Windsor Review of Legal and Social Issues, (2010) 28: 139-70.
Roadblocks to Laws for Healthy Eating and Activity. Canadian Medical Association Journal, (2010) 182(7): 687-92 (with N. Ries).
Cancer Surveillance in Canada: Analysis of Legal and Policy Frameworks and Tools for Reform. Health Law Journal, (2009) 17: 1-50 (with N. Ries).
Food labelling for healthier eating: is front-of-package labelling the answer? Manitoba Law Journal, (2009) 33(1): 87-130 (with T. Culham).
The Stem Cell Research Environment: A Patchwork of Patchworks. Stem Cell Reviews and Reports, (2009) 5(2): 82-88, doi: 10.1007/s12015-009-9071-3 (with T. Caulfield et al.).
International Stem Cell Environments: A World of Difference. Nature Reports Stem Cells, (2009) published online 16 April 2009, doi: 10.1038/stemcells.2009.61 (with T. Caulfield et al.).
Product regulation and the clinical translation of stem cell research. Stem Cell Reviews and Reports, (2009) 5(2): 135-39, doi: 10.1007/s12015-009-9059-z.
The challenges of regulating stem cell-based products. Trends in Biotechnology, (2008) 26(12): 653-58.
Obesity and the Law. In T.M. Bailey, T. Caulfield and N.M. Ries (eds.), Public Health Law and Policy in Canada (2nd ed.), 363-393. Toronto: LexisNexis Canada, 2008 (with Nola Ries).
The International Health Regulations to protect against global health threats: challenges and opportunities. Canadian Medical Association Journal, (2008) 179(1): 44-48 (with Kumanan Wilson and Christopher McDougall).
Tobacco Control and the Law in Canada. In T.M. Bailey, T. Caulfield and N.M. Ries (eds.), Public Health Law and Policy in Canada (2nd ed.), 247-300. Toronto: LexisNexis Canada, 2008.
Globalisation, harmonisation and the regulation of therapeutic products: the Australia New Zealand Therapeutic Products Authority project in global context. Canterbury Law Review, (2007) 13: 287-313.
Regulation of Stem Cell-Based Products. Health Law Journal, (2007) 15: 175-220 (with Erin Schroh).
Public Health. In C. Flood, J. Downie and T. Caulfield (eds.), Canadian Health Law and Policy (3rd ed.), 479-508. Toronto: LexisNexis Canada, 2007.
Healthy Communities: Public Health Law at the Supreme Court of Canada. In J. Downie and E. Gibson (eds.), Health Law at the Supreme Court of Canada, 81-110. Toronto, Irwin Law, 2007.
Human Security and International Law: Prospects and Problems (Oxford: Hart Publishing, 2007).
Small Island Developing States and International Trade: Special Challenges in the Global Partnership for Development? (2005) 6(2) Melbourne Journal of International Law 402-36
The Revised International Health Regulations and Restraint of National Health Measures. Health Law Journal, (2005) 13: 35-76.